PacBio Unveils a New Method for Comprehensive, Genome-Wide Tandem Repeat Analysis
Complete the form below to unlock access to ALL audio articles.
PacBio (NASDAQ: PACB), has announced the availability of a new computational analysis method for profiling more than a million tandem repeats (TRs) across the human genome using PacBio’s native long-read HiFi sequencing data. The Tandem Repeat Genotyping Tool (TRGT: pronounced as “target”) is intended to provide scientists with the ability to obtain a full characterization of the sequence and methylation status of TRs genome-wide.
Tandem repeats are genetic sequences that are repeated in series, and they can grow in length from parent to child. Importantly, TRs have been linked to many neurological disorders such as ALS and Huntington’s disease in addition to the number one cause of inherited mental intellectual disability, Fragile X syndrome.
“We developed TRGT to characterize the genetic and epigenetic variation in one of the most difficult variant classes, tandem repeats” said Michael Eberle, Vice President of Computational Biology at PacBio. “So far, tandem repeats have been understudied due to limitations in the ability of short-read sequencing technologies to sequence these regions of the genome. By combining HiFi sequencing and TRGT, we intend to provide scientists with the ability to explore and characterize these complicated genomic regions and, ultimately, better understand their biological impact.”
TRGT is intended to enable research scientists to characterize the sequence composition and structure, repeat unit length, and CpG methylation for each analyzed repeat allele and flanking sequence across the genome. The improved characterization of TR variation may aid in the tertiary analysis for disease causing loci. For example, TRGT can characterize the very long (thousands of base pairs) repeats associated with certain diseases. TRGT can also identify sequence composition changes that are potentially associated with pathogenic expansions in diseases such as cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome (CANVAS). Furthermore, because HiFi reads can identify CpG methylation, TRGT can identify hypermethylation signals like those observed with Myotonic Dystrophy expansions.
“The TRGT method is a major improvement on repeat expansion analysis and is helping us to discover new and potentially important variants that may be associated with disease in samples from individuals with inherited disorders,” said Stephan Zuchner, MD, PhD, Professor and Chief Genomics Officer of the Miller School of Medicine, University of Miami. Dr. Zuchner and his colleague, Matt Danzi, PhD, Scientist and bioinformatician, are focused on research into the characterization of repeat expansions in healthy and rare disease cohorts.
To improve usability, TRGT also comes with a companion tool, TRVZ, for visualizing the read pileups and methylation data for each repeat allele and flanking sequence analyzed.
TRGT and TRVZ are now available on GitHub: https://github.com/pacificBiosciences/trgt/
